Johnson & Johnson has added another piece to the data behind its effort to move Tecvayli into earlier-line therapy for multiple myeloma, including the first relapse setting. In the MajesTEC-9 trial, ...
Investigators said he pointed a gun at officers when they responded to reports of a man kicking down doors to four different homes ‘Weird even for him’: Nicolle on Trump’s bizarre string of posts, AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results